slotkoers
Korea S.E.
00:00:00 25-03-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.020
KRW
|
+9,54%
|
|
-.--%
|
-67,58%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
321.353
|
337.280
|
712.301
|
842.433
|
544.996
|
516.267
|
Bedrijfswaarde
1 |
309.494
|
379.655
|
741.191
|
861.281
|
588.273
|
567.785
|
K/w-verhouding
|
-15,6
x
|
-26,8
x
|
-16,5
x
|
-15,8
x
|
-10,1
x
|
104
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
51,3
x
|
38,5
x
|
68,7
x
|
64,7
x
|
48,4
x
|
47,9
x
|
Bedrijfswaarde/omzet
|
49,4
x
|
43,4
x
|
71,5
x
|
66,1
x
|
52,2
x
|
52,7
x
|
Bedrijfswaarde/EBITDA
|
-22,9
x
|
-19,4
x
|
-21,9
x
|
-22,1
x
|
-14,7
x
|
-10,9
x
|
Bedrijfswaarde/FCF
|
-15,6
x
|
-16,4
x
|
-39,5
x
|
-52
x
|
-42,3
x
|
-21,4
x
|
FCF Yield
|
-6,41%
|
-6,1%
|
-2,53%
|
-1,92%
|
-2,36%
|
-4,67%
|
Price to Book
|
9,21
x
|
3,14
x
|
6,01
x
|
7,12
x
|
6,37
x
|
4,61
x
|
Aantal aandelen (in duizenden)
|
49.630
|
62.459
|
67.838
|
75.050
|
79.562
|
82.868
|
Referentieprijs
2 |
6.475
|
5.400
|
10.500
|
11.225
|
6.850
|
6.230
|
Datum van publicatie
|
18/03/19
|
19/03/20
|
19/03/21
|
21/03/22
|
20/03/23
|
5/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
6.269
|
8.749
|
10.372
|
13.020
|
11.263
|
10.769
|
EBITDA
1 |
-13.503
|
-19.545
|
-33.851
|
-38.988
|
-40.149
|
-52.328
|
Bedrijfsresultaat (EBIT)
1 |
-14.434
|
-24.496
|
-41.197
|
-47.440
|
-49.653
|
-60.829
|
Operationele Marge
|
-230,24%
|
-279,98%
|
-397,21%
|
-364,36%
|
-440,86%
|
-564,84%
|
Resultaat voor belastingen (EBT)
1 |
-22.409
|
-11.343
|
-43.138
|
-50.095
|
-56.658
|
-37.485
|
Nettowinst (verlies)
1 |
-20.453
|
-11.429
|
-41.439
|
-50.336
|
-53.505
|
5.261
|
Nettomarge
|
-326,27%
|
-130,63%
|
-399,54%
|
-386,6%
|
-475,06%
|
48,85%
|
WPA
2 |
-415,2
|
-201,5
|
-636,1
|
-709,8
|
-679,4
|
60,00
|
Free Cash Flow
1 |
-19.826
|
-23.163
|
-18.775
|
-16.554
|
-13.904
|
-26.494
|
FCF-marge
|
-316,26%
|
-264,74%
|
-181,02%
|
-127,14%
|
-123,46%
|
-246,01%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
18/03/19
|
19/03/20
|
19/03/21
|
21/03/22
|
20/03/23
|
5/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
42.375
|
28.889
|
18.848
|
43.276
|
51.518
|
Nettokaspositie
1 |
11.859
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-2,168
x
|
-0,8534
x
|
-0,4834
x
|
-1,078
x
|
-0,9845
x
|
Free Cash Flow
1 |
-19.826
|
-23.163
|
-18.775
|
-16.554
|
-13.904
|
-26.494
|
ROE (netto-inkomsten/eigen vermogen)
|
-54,7%
|
-16,1%
|
-36,4%
|
-42,6%
|
-54,8%
|
-37,1%
|
ROA (netto-inkomsten/totale activa)
|
-14,5%
|
-12,1%
|
-13,3%
|
-15,4%
|
-17,7%
|
-21,5%
|
Totale activa
1 |
141.261
|
94.332
|
311.794
|
327.572
|
301.976
|
-24.500
|
Nettoactief per aandeel
2 |
703,0
|
1.721
|
1.748
|
1.576
|
1.076
|
1.353
|
Cashflow per aandeel
2 |
16,70
|
204,0
|
226,0
|
155,0
|
74,10
|
7,960
|
Capex
1 |
638
|
11.723
|
857
|
1.379
|
926
|
590
|
Capex/omzet
|
10,17%
|
133,99%
|
8,27%
|
10,59%
|
8,22%
|
5,48%
|
Datum van publicatie
|
18/03/19
|
19/03/20
|
19/03/21
|
21/03/22
|
20/03/23
|
5/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -67,58% | 128 mln. | | +7,86% | 113 mld. | | +10,39% | 106 mld. | | +0,41% | 22,27 mld. | | -11,94% | 22,22 mld. | | -5,99% | 19,43 mld. | | -37,36% | 17,87 mld. | | -5,53% | 17,24 mld. | | +7,05% | 14,29 mld. | | +36,11% | 12,52 mld. |
Biotherapeutische geneesmiddelen
|